Bringing More Options to Your Operating Room

The expansion of our EMERPHED® (ephedrine sulfate) family of products features innovative and high-quality options to fit your OR needs. Now available in a 5 mL and the first and only 10 mL ready-to-administer syringe.

Want one less thing to worry about in the OR? Choose the simplicity, stability, and safety of EMERPHED® ready-to-use ephedrine from Nexus Pharmaceuticals.

Ready to use. Less waste.

And no mixing means no mix-ups.

Redefining the Standards of Patient Care

Simple

No Compounding

Any trained staff can administer EMERPHED® with less chance for error.

Stable

Less Ordering

EMERPHED® is ready when you need it
with less frequent
re-stocking/ordering.

Safe

No Diluting or Mixing

EMERPHED® is easier to use with less waste and chance for error.

Share and compare.
Take our short survey.

What does ready-to-use mean for your OR protocol? Compare your process with that of your colleagues.

No mixing.
No mix-ups.

See why the FDA recommends the use of non-compounded, manufacturer-prepared products.

What important safety information should I know?

CONTRAINDICATIONS
None

WARNINGS AND PRECAUTIONS
EMERPHED® can cause pressor effects with concomitant use with oxytocic drugs. Can also cause tachyphylaxis with repeated administration of ephedrine.

ADVERSE REACTIONS
Most common adverse reactions during treatment: nausea, vomiting, and tachycardia.
To report SUSPECTED ADVERSE REACTIONS, contact Nexus Pharmaceuticals at (855) 642-2594 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

DRUG INTERACTIONS
Can include: interactions that augment pressor effect; interactions that antagonize the pressor effect; guanethidine; rocuronium; epidural anesthesia; theophylline; cardiac glycosides.

OVERDOSAGE
Overdose of EMERPHED® can cause a rapid rise in blood pressure. In the case of an overdose, careful monitoring of blood pressure is recommended. If blood pressure continues to rise to an unacceptable level, parenteral antihypertensive agents can be administered at the discretion of the clinician.

INDICATIONS AND USAGE
Ephedrine Sulfate injection is an alpha- and beta-adrenergic agonist and a norepinephrine-releasing agent that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.

For more information, see full Prescribing Information.

EPH-134-v2